XML 63 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Investments (Details)
12 Months Ended
Dec. 31, 2023
USD ($)
property
Dec. 31, 2022
USD ($)
Feb. 28, 2023
$ / shares
Jun. 30, 2022
Dec. 31, 2021
Mar. 31, 2017
Investment in available for sale securities            
Number of medical office and life science properties | property 10          
AlerisLife Inc            
Investment in available for sale securities            
Investment in equity securities acquisition, share price (in dollars per share) | $ / shares     $ 1.31      
Corporate Joint Venture            
Investment in available for sale securities            
Principal amount of debt $ 1,076,625,000          
AlerisLife Inc | Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Carrying Amount            
Investment in available for sale securities            
Investments in Five Star 0 $ 5,880,000        
Realized gain $ 8,126,000          
Unrealized loss   $ 25,660,000        
Seaport Innovation LLC | Corporate Joint Venture            
Investment in available for sale securities            
Equity method investment ownership percentage 10.00%     20.00% 20.00% 55.00%
Principal amount of debt $ 620,000,000          
LSMD Fund REIT LLC | Corporate Joint Venture            
Investment in available for sale securities            
Equity method investment ownership percentage 20.00%          
Principal amount of debt $ 456,625,000